More GLP-1 and GIP receptor dual agonists are coming #obesity#T2D Will any of them approach the effectiveness of tirzepatide? Possibly, unlikely.... https://t.co/KmlsbbyUUf
I-M-150847, a novel GLP-1 and GIP receptor dual agonist, reduces body weight gain and improves glycemic control in the rodent model of type 2 diabetes and obesity https://t.co/45xjJzyd6B
@_JoeMcKellar what`s the PI4P binding protein domain you used? I am interested in that. I used GFP-P4M(PI4P bisosensor) which is not great with fixed imaging.
Do you live in @SanDiegoCounty and need a fast and accurate #COVID19 PCR test for travel, school or other reasons? Self-schedule a $65 drive-up @UCSDHealth test!
https://t.co/R0Y9jVtJ66